What is Bausch Health Companies's finished goods?

Bausch Health Companies (BHC) reported finished goods of $946M in Q1 2026.

How has Bausch Health Companies's finished goods changed year-over-year?

Bausch Health Companies's finished goods decreased by 2.0% year-over-year, from $965M to $946M.

What is the long-term trend for Bausch Health Companies's finished goods?

Over 3 years (2022 to 2025), Bausch Health Companies's finished goods has grown at a 13.1% compound annual growth rate (CAGR), from $666M to $963M.

What does finished goods mean?

Completed products ready for sale, valued at the lower of cost or net realizable value.

Bausch Health Companies BHC Finished goods

Finished goods at other companies

PBH

Prestige Consumer HealthcarePBH

$144.16M+11.7%

Bausch + LombBLCO

$643M-5.0%

OrganonOGN

$734M-5.5%

HRO

HarrowHROW

$8.43M+54.5%

Neurocrine BiosciencesNBIX

——

ViatrisVTRS

——

Other financials

Income statement

See full

Revenue$2.5B+11.7%

Operating income-$950.0M-444%

Net income-$1.4B-2,353%

EPS (diluted)-$3.82-2,287%

Balance sheet

See full

Cash & equivalents$1.3B+13.4%

Total debt$20.8B-3.5%

Total equity-$2.1B-74.0%

Total assets$24.5B-7.3%

Cash flow

See full

Operating cash flow$230.0M+9.0%

CapEx$109.0M-5.2%

Free cash flow$121.0M+26.0%

Valuation

See full

Market cap$1.79B-15.9%

Enterprise value$21.24B-5.6%

P/S0.2×0.0×

Profitability

See full

Gross margin71.4%—

Operating margin5.6%-10.3pp

Net margin-1.9%-0.9pp

FCF margin9.8%-2.8pp

Returns & leverage

See full

Return on equity-70.1%—

Debt / equity45.2×—

Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:InventoryFinishedGoods.

The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch Health Companies's finished goods.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bausch Health Companies's finished goods?: Bausch Health Companies (BHC) reported finished goods of $946M in Q1 2026.
How has Bausch Health Companies's finished goods changed year-over-year?: Bausch Health Companies's finished goods decreased by 2.0% year-over-year, from $965M to $946M.
What is the long-term trend for Bausch Health Companies's finished goods?: Over 3 years (2022 to 2025), Bausch Health Companies's finished goods has grown at a 13.1% compound annual growth rate (CAGR), from $666M to $963M.
What does finished goods mean?: Completed products ready for sale, valued at the lower of cost or net realizable value.